2_氨基~1

Size: px

Start display at page:

Download "2_氨基~1"

麟贲
7 years ago
Views:

1 ,No. 4 Chemistry & Bioengineering,, (, ) :,, 2,8, 1 HNMR IR :; ; : TQ :A : (2005) , [13 ] [4 ],,,,8, 1 4 7, 1 8 R H p2ch3 p2cl p2f p2ch3 O p2no2, 4, X4 (), Shimadzu F T2 IR8000 ( KBr ), Mercury2plus 400NMR (DMSO2d6, TMS ),Carlo2Frba21106,, KSCN, CR AR, , [ 5 ] mol 8 ml SOCl2, h HCl,SOCl2, 30 ml mol KSCN, h,, 214, mol 20 ml mol,, 1 h,,,,, DM F = 5 2 ( ), ,, DMF DMSO 1 2 : :( ),, :,,

4 86 Youjiang Medical Journal 2007,Vol. 35 No. 1 after breast conservation therapy[j ]. Oncology,2003,17 (8) : [ 3 ],. [J ].,2003,23 (10) : [4 ] Fisher B,Anderson S,Bryant J,et al. Twenty2year follow2up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer[j ]. N Engl J Med,2002,347 (16) : [ 5 ]Veronesi U,Cascinelli N,Mariani L,et al. Twenty2year follow2up of a randomized study comparing breast2conserving surgery with radical mastectomy for early breast cancer [ J ]. N Engl J Med, 2002,347 (16) : [ 6 ],. [J ].,2003,18 (4) : [ 7 ]Cance WG,Carey LA,Calvo BF,et al. Long2term outcome of neo2 adjuvant therapy for locally advanced breast carcinoma [ J ]. Ann Surg,2002,236 (2) : [ 8 ],,,. [J ].,2003,10 (5) : [ 9 ] Stoher A, Allen R, Linares L. Breast conservation therapy with concomitant breast reduction in large - breasted women[j ]. Breast J,2003,9 (4) : [ 10 ]Asgeirsson KS, Mc Culley SJ, Pinder SE,et al. Size of invasive breast cancer and risk of local recurrence after breast2conserva tiontherapy[j ]. Eur J Cancer,2003,39 (17) : [ 11 ]Bijker N,Rutgers EJ,Duchateau L,et al. Breast2conserving ther2 apy for Paget disease of the nipple : a prospective European Or2 ganization for Research and Treatment of cancer study of 61 pa2 tients[j ]. Caneer,2001,91 (3) : [ 12 ],. [J ].,2000,20 (1) :39. [ 13 ],. [J ].,2001,11 (6) : [14 ]Smitt MC,Nowels K,Carlson RW,et al. Predictors of reexcision findings and recurrence after breast conservation[j ]. Int J Radiat Oncol Biol Phys,2003,57 (4) : [ 15 ],,. [J ].,2001,21 (9) : [ 16 ],,. [J ].,2002,29 (6) : [ 17 ],,. 21 [J ].,2002,19 (6) :886. [ 18 ],,. 25 [J ].,2002,17 (1) : [ 19 ]Schrenk P, Hatzl Griesenhofer M,Shamiyeh A,et al. Follow - up of sentinel node negative breast cancer patients without axillary lymph node dissection[j ]. J Surg Oncol,2001,77 (3) : [ 20 ] Polgar C,Fodor J,Orosz Z,et al. The effect of tumour bed boost on local control after breast conserving surgery. First results of the randomized boost trial of the National Institute of Oncology [J ]. Magy Onkol,2001,45 (5) : [ 21 ] Ring A,Webb A,Ashley S,et al. Is surgery necessary after com2 plete clinical remission following neoadjuvant chemotherapy for early breast cancer[j ]. J Clin Oncol,2003,21 (24) : [ 22 ] Dixon J M, Anderson TJ, Miller WR. Neoadjuvant endocrine therapy of breast cancer :a surgical perspective[j ]. Eur J Canc2 er,2002,38 (17) : [ 23 ]Lee J M,Orel SG,Czerniecki BJ,et al. MRI before reexcision sur2 gery in patient s wit h breast cancer [J ]. AJ R Am J Roentgenol, 2004,182 (2) : ( : : ) ( :), (, ) ; ; : (2007) :R 730 :A,,,,,,,,,,,, : ( ),,,

9 21 3 () Vol. 21 No Journal of Higher Correspondence Education (Natural Sciences) J une 2007 : (2007) (22) ,, (, ) :,, :; ; : G :A,, [1 ],??,,, [ 1 ], [2 ],, Likert 5, :, , 4, 2 330,, 8, 322, %, (1) 1 : %, %,,,, 1 % % % (2), %, 2. 2 (1) 2 % % % , %, %, %, : ;,, ; (2) 62 3 :

13 T207 A (2007) %

16 19 6 () Vol. 19 No Journal of Higher Correspondence Education (Natural Sciences) December 2006 : (2006) (19) , (, ) :,,,,, : ;; : G :A,,,,,,,, ,,,,,,, ;, 1/ 3,,,,,,, 1. 2,,,,,,, ,,,,,,,,,,,,, 54 3 : China Academic Journal Electronic Publishing House. All rights reserved.

18 ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,

19 1166 CHEMICAL INDUSTRY AND ENGINEERING PROGRESS /-Fenton RhB /(Fe/CNTs) SEM EDS XRD -Fenton Rhodamin B (RhB) 1.2 V 0.1 m 3 /h 120 min 5mg/L RhB 92.1% H 2 O 2 RhB E-Fenton -Fenton RhB X A Degradation of RhB by electro-fenton reaction using a nanoscale Fe/CNTs composites cathode MEI Tao LIU Juan LI Jinpo ZHANG Lizhi AI Zhihui (School of Chemistry Central China Normal University Wuhan Hubei China) Abstract In this study a nanoscale iron/carbon nanotube (CNT) composite cathode was synthesized and evaluated by X-ray diffraction (XRD) scanning electron microscopy (SEM) and engery dispersive X-ray spectroscopy (EDX) respectively. It was found that 92.1% degradation of 5 mg/l Rhodamin B (RhB) was achieved in the presence of 1.2V potential and air (0.1m 3 /h) based on the eletro-fenton reaction using a nanoscale Fe/CNTs composite cathode at a neutral ph. The results indicated that both H 2 O 2 and iron ions could be effectively generated by electrochemical reduction from Fe/CNTs cathode and RhB could be rapidly eliminated. Key words carbon nanotube nanoscale iron electro-fenton reaction RhB -Fenton (E-Fenton) [1 2] E-Fenton H 2 O 2 [3] (CNTs) E-Fenton Fe 2+ Fe 3+ ph 3 H 2 O 2 Fe(Ш) ph=3 10 Fenton [4] NaBH 4 FeCl 3 / [5] / Fe/CNTs Rhodamin B (RhB) E-Fenton RhB CNTs No E mail jennifer.ai@mail.ccnu.edu.cn

20 42 1 () Vol. 42 No J OU RNAL OF HUAZHON G NORMAL UNIV ERSIT Y(Nat. Sci. ) Mar : (2008) GhRGPL2,,,,,, 3 (, ) : cdna 1 R GP,GhRGPL2, 359 R GP., GhR GPL2, :3, , 190, Northern, GhRGPL2.,. GhR GPL2, 10 d,., GhR GPL2. : ; R GPL ; ; ; : X : A.,, 20 %25 %,, 2 %5 % [1 ]. 4 : [2 ].,, [3 ].,,,., [4 ], [5 ], [628 ]. Dhugga, : UDP2Glc,. UDP2Glc UDP2 GlcUDP2Xyl UDP2Gal. PsR GP1 ( P. sativum Reversibly Glyco2 sylated Polypeptide21) ( UDP2Glc 2Xyl 2Gal), ( )., PsR GP1 ADP2Glc,R GP [ 9211 ]., R GP [ 9213 ]. R GP ( CelA) 2, 2,, DXD [ ],GhCelA UDP2Glc. R GP, R GP 2,. Dhugga R GP, ,,. 1 R GP, R GP [ 9, 17 ]. Delgado R GP, At R GPs, AtR GP1 At R GP2,At R GP2 AtR GP1 7, R GP 2. : : (973) (2004CB117304). 3. E2mail : ccnu. edu. cn

22 21 4 () Vol. 21 No Journal of Higher Correspondence Education (Natural Sciences) August 2007 : (2007) (15) (, ) :,, : ;; :X78 :A,,, 1.,,,,,,,,,,,,,, 2.,,,,,,,,,,,,, 48 3 :

23 ! SHANXI FOOD INDUSTRY * mo1/L 20% ~ 30% 20% ~ 30% 30% ~ 40% 4 % ~ 5 % % SHZ - D DF - 101B CS101- IEBN mol/l 10h 1 *

24 (NSAIDs) R453 A (2007) , 20-60mg/L80mg/L ,,, (NSAIDs) NSAIDs NSAIDs, (MC32R) ,, (colchicine),atp ph C 22H 25O 6N= (allopurinol),,,,,,,,,,,,, 3.3 C 5H 4N 4O (probenecid):,,,,,, (sulfinpyrazone):,,,, (benzbromarone),,, 3.4 (NSAIDS) C 17H 16O 3Br (phenylbutazone)

26 ( ),,,,, CA I,,,, 2001, [ 1 ] 3 1,, [ 2 ], [ 3 ],,, :, [ 4 ],,,,,,,, ;,,,, 8

27 ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,

2_氨基~1

2_氨基~1 86 Youjiang Medical Journal 2007,Vol. 35 No. 1 after breast conservation therapy[j ]. Oncology,2003,17 (8) :1118-1128. [ 3 ],. [J ].,2003,23 (10) :589-591. [4 ] Fisher B,Anderson S,Bryant J,et al. Twenty2year